10-Q: Centrus Energy Corp. Q2 2026: HALEU Expansion and Financial Shifts
Quarterly Report
Centrus Energy Corp. reports on its HALEU expansion efforts, strategic partnerships, and financial performance for the quarter ended June 30, 2026, highlighting increased investments and evolving market dynamics.
Summary
- Centrus Energy Corp. filed its Form 10-Q for the quarter ended June 30, 2026, detailing its financial performance and operational updates.
- The company reported total revenue of $176.1 million for the three months ended June 30, 2026, an increase from $154.5 million in the same period last year.
- Net income for the quarter was $16.8 million, a decrease from $28.9 million in the prior year's quarter, impacted by increased advanced technology costs and SG&A expenses.
- Significant investments are being made in expanding uranium enrichment capacity in Piketon, Ohio, and centrifuge manufacturing in Oak Ridge, Tennessee.
- The company secured a $900 million task order from the DOE for HALEU production and is exploring a joint venture with Oklo Inc. for deconversion services.
- Centrus has a substantial backlog of $4.5 billion as of June 30, 2026, extending to 2040, with a significant portion being contingent sales commitments.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this filing as cautiously optimistic. While there are significant investments and strategic partnerships, the reliance on government funding and the complexities of international trade and sanctions introduce notable uncertainties.
Positives
- Total revenue increased by 14% to $176.1 million for the three months ended June 30, 2026, compared to $154.5 million in the prior year.
- Secured a $900 million task order from the DOE for HALEU production, with options for an additional $170 million.
- Entered into a letter of intent with Oklo Inc. to supply HALEU for up to five reactors, with deliveries potentially starting in 2029.
- Received a $62.4 million clean energy manufacturing credit allocation from the IRS for its Oak Ridge facility.
- Maintains a strong liquidity position with $1.9 billion in cash and cash equivalents as of June 30, 2026.
- Backlog increased to $4.5 billion as of June 30, 2026, indicating future revenue potential.
Negatives
- Net income decreased by 42% to $16.8 million for the three months ended June 30, 2026, compared to $28.9 million in the prior year.
- Selling, general, and administrative costs increased by 96% to $26.2 million, largely due to a non-cash stock compensation charge.
- Advanced technology costs increased significantly by 227% to $10.8 million, related to expansion projects.
- Gross profit for the Technical Solutions segment was a loss of $1.7 million, a decrease from a profit of $3.2 million in the prior year.
- The company faces ongoing risks related to international trade restrictions, sanctions, and potential disruptions in the supply of LEU from Russia.
Risks
- Reliance on U.S. government funding and appropriations for contracts, with potential delays or terminations impacting operations.
- Uncertainty regarding the issuance of waivers for Russian LEU imports and the ability of TENEX to secure export licenses, impacting supply chain reliability.
- Potential for increased costs due to tariffs, sanctions, or other trade restrictions on imported materials and services.
- The current DOE budget proposal for fiscal year 2027 does not include funding for the operation of the HALEU cascade, and DOE has indicated it does not intend to exercise further options under the HALEU Operation Contract.
- The company may require additional capital for growth, and future equity issuances could dilute existing stockholders.
- Legal proceedings related to alleged off-site contamination from past operations at the Portsmouth GDP site continue, with potential financial implications.
- The company's ability to deploy advanced centrifuge technology is dependent on continued U.S. government funding and support.
Future Outlook
The company anticipates having adequate liquidity for at least the next 12 months, supported by its cash position and expected customer payments. However, future outlook is contingent on market conditions, international trade policies, government funding, and the successful expansion of its enrichment and manufacturing capabilities. The company is exploring strategic partnerships and potential transactions to drive growth.
Management Comments
- Stock-based compensation charge of $17.2 million due to reclassification of Board RSU grants from equity to liability significantly impacted SG&A expenses.
- Investment income increased due to a higher cash balance from convertible note issuance and ATM program proceeds.
- The company is working with DOE on future agreements to enable private operation of the HALEU cascade on a commercial basis.
- Centrus plans to leverage its multi-billion-dollar uranium enrichment expansion to meet its growing backlog and targets future commercial-scale HALEU production.
Industry Context
StockSavvy.ai notes that Centrus operates in a critical but complex sector. The global push for carbon-free energy is driving demand for nuclear power, and consequently, for enriched uranium like HALEU and LEU. However, geopolitical tensions, particularly concerning Russian supply, and evolving trade policies create significant market volatility and supply chain risks for companies like Centrus.
Comparison to Industry Standards
- The company's focus on HALEU production aligns with the U.S. government's strategic goal to establish domestic advanced nuclear fuel capabilities, as outlined in the Energy Act of 2020 and supported by DOE programs like ARDP.
- Centrus's expansion plans for LEU and HALEU enrichment capacity are aimed at addressing potential supply chain gaps and reducing reliance on foreign sources, a key concern for U.S. energy security.
- The company's efforts to secure contracts with the DOE for HALEU production are in line with industry trends where government support is crucial for developing new nuclear technologies and infrastructure.
- The SWU spot price has reached $200 per SWU as of June 30, 2026, reflecting increased market demand driven by geopolitical uncertainty and interest in nuclear power, a trend observed across the broader nuclear fuel market.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Rights Agreement Amendment | Seventh Amendment to the Section 382 Rights Agreement extended the Final Expiration Date from June 30, 2026 to June 30, 2029 and increased the purchase price for Series A Participating Cumulative Preferred Stock. | 2026-06-18 | Aimed at preserving the long-term value of net operating loss carry-forwards and other tax benefits for stockholders. |
Legal Proceedings
- Class action complaint filed by McGlone Plaintiffs regarding alleged off-site contamination from Portsmouth GDP site operations.
- Complaint filed by Brad Allen Lykins estate alleging radiation release violations causing death.
- Complaint filed by Christian Rose alleging radiation release violations causing cancer.
- Complaint filed by Joshua Shaw alleging radiation release violations causing Acute Myeloid Leukemia.
- Complaint filed by Julia Dunham alleging radiation release violations causing death.
- DOE assertion of approximately $9.6 million in liability for Joppa Power Plant D&D costs against Enrichment Corp.
Stakeholder Impact
- Shareholders may experience dilution from potential future equity issuances, but also benefit from the preservation of tax assets through the Rights Agreement amendment.
- Employees are impacted by investments in expansion projects and the transition to high-rate manufacturing, potentially leading to job creation and skill development.
- Customers in the LEU segment rely on Centrus for nuclear fuel components, with supply chain stability being a key concern due to geopolitical factors.
- Suppliers may be affected by changes in demand and the company's strategic expansion plans.
- Creditors' positions may be influenced by the company's liquidity, debt levels, and future capital raising activities.
Next Steps
- Continue to work with DOE on future agreements to enable private operation of the HALEU cascade on a commercial basis.
- Pursue opportunities for strategic partnerships, including the potential joint venture with Oklo Inc. for deconversion services.
- Complete construction activities for the training, operations, and maintenance facility in Piketon, Ohio, which began in early 2026.
- Transition the Oak Ridge centrifuge manufacturing plant to high-rate manufacturing to support thousands of advanced centrifuges.
- Submit bids for RFTOPs under the HALEU Deconversion Contract.
- Continue to monitor and address risks related to international trade, sanctions, and supply chain disruptions.
Key Dates
| Date | Description |
|---|---|
| 2022-11-17 | DOE awarded HALEU Operation Contract to Centrus. |
| 2024-11-07 | Company issued 2.25% Convertible Notes due 2030. |
| 2025-01-10 | Company informed IRS granted $62.4 million credit allocation for Oak Ridge facility. |
| 2025-03-26 | Company redeemed all 8.25% Notes. |
| 2025-08-18 | Company issued 0% Convertible Notes due 2032. |
| 2026-01-05 | DOE announced ACO awarded $900.0 million task order under HALEU Production Contract. |
| 2026-06-18 | Company entered into Seventh Amendment to the Section 382 Rights Agreement. |
| 2026-06-30 | Quarterly period ended; DOE issued amendment to HALEU Operation Contract. |
Recommendation
holdCentrus Energy Corp. presents a mixed picture. The company is strategically positioned to benefit from the growing demand for nuclear fuel and has secured significant government contracts and strategic partnerships. However, substantial investments, increased operating costs, reliance on government funding, and significant geopolitical and regulatory risks, particularly concerning Russian supply, introduce considerable uncertainty. The current financial performance shows a decline in net income despite revenue growth. Therefore, a 'hold' recommendation is appropriate, pending clearer visibility on the successful execution of expansion plans and mitigation of external risks.
Keywords
uranium enrichment, HALEU, LEU, nuclear fuel, centrifuge technology, DOE contract, American Centrifuge Plant, supply chain
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.